Our results provide further insight into these processes by suggesting that an event-related decrease in anti-β1AR Ab in ACS patients, given that levels in non-ACS patients with known atherosclerosis demonstrated similar concentrations to healthy controls. This evidence concerns the gene ADRB1 and atherosclerosis.